Member Login
Home » Investing Videos » A Closer Look At GlaxoSmithKline plc

A Closer Look At GlaxoSmithKline plc

VIDEO: Two Fools puts GlaxoSmithKline plc (LON:GSK) under the spotlight.

Posted by
Nate Weisshaar
Nate 'The Snake' Weisshaar is a senior analyst on the Fool's global equities research team, based in London, and specialising in coverage of European and U.K. companies. His investing interests include banks and other financial companies. Away from the market, Nate enjoys, socc... um, football, mindless action movies, and free running. Before coming to the Fool Nate spent five years providing consulting services for small banks in the United States. He is a qualified Chartered Financial Analyst (CFA).
Published

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Following Motley Fool analyst Nate Weisshaar’s insights on AstraZeneca, he now turns his attention to Big Pharma rival GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) after the Serious Fraud Office has launched a criminal investigation into its commercial practices…

https://youtu.be/jjiqKOnzbc4

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

The Motley Fool has recommended shares in GlaxoSmithKline.

More on Investing Videos

Investing Videos

Is the FTSE 100 overvalued?

| Owain Bennallack

VIDEO: One Fool scrutinises the FTSE 100 (INDEXFTSE: UKX).

Read more »

Investing Videos

Can the price of Rio Tinto plc & BHP Billiton plc double again?

| Owain Bennallack

VIDEO: One Fool ponders the near-term future of Rio Tinto plc (LON:RIO) and BHP Billion plc (LON:BLT)

Read more »

Investing Videos

Why these expensive shares could keep falling in 2017

| Owain Bennallack

VIDEO: One Fool doesn't like the near-term forecast for consumer staples giants...

Read more »

Oil rig
Investing Videos

BP & Shell should be big winners from the big OPEC deal

| Owain Bennallack

VIDEO: One Fool looks at the beneficiaries from OPEC's decision to cut oil production.

Read more »

Investing Videos

Should we expect a Santa Rally for the FTSE 100?

| Owain Bennallack

VIDEO: One Fool looks at the hopes for the FTSE 100 (INDEXFTSE:UKX) this month.

Read more »

Investing Videos

Is it too late to buy Lloyds Banking Group plc?

| Owain Bennallack

VIDEO: One Fool assesses Lloyds Banking Group plc (LON:LLOY).

Read more »

Investing Videos

Is the Trump win boosting the FTSE 100?

| Owain Bennallack

VIDEO: One Fool assesses the state of the FTSE 100 (INDEXFTSE:UKX).

Read more »

Investing Videos

Are Lloyds Banking Group shares now doomed to slump?

| Owain Bennallack

VIDEO: One Fool looks at the government's decision to dispose of its Lloyds shares on the open market.

Read more »